Terms: = Pancreatic cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI
4818 results:
1. Strategies to Perform Emergency Laparoscopic Partial Liver Resection for Ruptured Hepatocellular Carcinoma.
Tsunematsu M; Onda S; Shirai Y; Abe K; Horiuchi T; Haruki K; Furukawa K; Okui N; Taniai T; Ikegami T
Anticancer Res; 2024 May; 44(5):2171-2176. PubMed ID: 38677754
[TBL] [Abstract] [Full Text] [Related]
2. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
[TBL] [Abstract] [Full Text] [Related]
3. The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis.
Cai X; Li X; Liang C; Zhang M; Dong Z; Yu W
Sci Rep; 2024 Apr; 14(1):9474. PubMed ID: 38658636
[TBL] [Abstract] [Full Text] [Related]
4. The pancreatic cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
[TBL] [Abstract] [Full Text] [Related]
5. A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With pancreatic Ductal Adenocarcinoma.
Sun X; Song H; Sun X; Liao C; Wang G; Xu Y; Li L; Han Y; Xu C; Wang W; Cai S; Liang H; Yu H
Cancer Invest; 2024 Mar; 42(3):226-242. PubMed ID: 38616304
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer.
Zeng D; Yu C; Chen S; Zou L; Chen J; Xu L
World J Surg Oncol; 2024 Apr; 22(1):93. PubMed ID: 38605359
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
8. The high FKBP1A expression in WBCs as a potential screening biomarker for pancreatic cancer.
Watcharanurak P; Mutirangura A; Aksornkitti V; Bhummaphan N; Puttipanyalears C
Sci Rep; 2024 Apr; 14(1):7888. PubMed ID: 38570626
[TBL] [Abstract] [Full Text] [Related]
9. Highly sensitive serum volatolomic biomarkers for pancreatic cancer diagnosis.
Martínez-Moral MP; Tena MT; Martín-Carnicero A; Martínez A
Clin Chim Acta; 2024 Apr; 557():117895. PubMed ID: 38561063
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of URO17® to improve non-invasive detection of bladder cancer.
Porten SP; Wang EY; Vohra P; Carroll PR; Jahanfard S; Kim NW
Urol Oncol; 2024 Jun; 42(6):176.e21-176.e28. PubMed ID: 38553264
[TBL] [Abstract] [Full Text] [Related]
11. A meta-analysis on the efficacy of endoscopic ultrasonography for treatment of pancreatic cancer.
Xuan M; Li N; Wu C
Clinics (Sao Paulo); 2024; 79():100348. PubMed ID: 38552386
[TBL] [Abstract] [Full Text] [Related]
12. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract] [Full Text] [Related]
13. Consistency between the National Patient Register and the Swedish cancer Register.
Sakakibara S; Pazzagli L; Linder M
Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5780. PubMed ID: 38511251
[TBL] [Abstract] [Full Text] [Related]
14. Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial.
van Bodegraven EA; Balduzzi A; van Ramshorst TME; Malleo G; Vissers FL; van Hilst J; Festen S; Abu Hilal M; Asbun HJ; Michiels N; Koerkamp BG; Busch ORC; Daams F; Luyer MDP; Ramera M; Marchegiani G; Klaase JM; Molenaar IQ; de Pastena M; Lionetto G; Vacca PG; van Santvoort HC; Stommel MWJ; Lips DJ; Coolsen MME; Mieog JSD; Salvia R; van Eijck CHJ; Besselink MG;
Lancet Gastroenterol Hepatol; 2024 May; 9(5):438-447. PubMed ID: 38499019
[TBL] [Abstract] [Full Text] [Related]
15. Synthesis and biological activity of 11-Oxygenated and heterocyclic estrone analogs in pancreatic cancer monolayers and 3D spheroids.
Alseud K; Ostlund T; Durymanov M; Reineke J; Halaweish F
Bioorg Med Chem; 2024 Apr; 103():117678. PubMed ID: 38489997
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic factors of pancreatic tumors in children and adolescents: a population study based on the surveillance, epidemiology, and end results database.
Qi X; Zhou B; Liang F; Wang X
BMC Gastroenterol; 2024 Mar; 24(1):108. PubMed ID: 38486208
[TBL] [Abstract] [Full Text] [Related]
17. Polycyclic Aromatic Hydrocarbons and pancreatic cancer: An Analysis of the Blood Biomarker,
Nguyen S; Carlson H; Yoder A; Bamlet WR; Oberg AL; Petersen GM; Carmella SG; Hecht SS; Jansen RJ
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474816
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of the LiMAx test vs. the APRI+ALBI score for clinical utility in preoperative risk assessment in patients undergoing liver surgery - A European multicenter study.
Santol J; Ammann M; Reese T; Kern AE; Laferl V; Oldhafer F; Dong Y; Rumpf B; Vali M; Wiemann B; Ortmayr G; Brunner SE; Probst J; Aiad M; Jankoschek AS; Gramberger M; Tschoegl MM; Salem M; Surci N; Thonhauser R; Mazari V; Hoblaj T; Thalhammer S; Schmelzle M; Oldhafer KJ; Gruenberger T; Starlinger P
Eur J Surg Oncol; 2024 Apr; 50(4):108048. PubMed ID: 38471374
[TBL] [Abstract] [Full Text] [Related]
19. Feasibility of proton dosimetry overriding planning CT with daily CBCT elaborated through generative artificial intelligence tools.
Rossi M; Belotti G; Mainardi L; Baroni G; Cerveri P
Comput Assist Surg (Abingdon); 2024 Dec; 29(1):2327981. PubMed ID: 38468391
[TBL] [Abstract] [Full Text] [Related]
20. Survival-Associated Cellular Response Maintained in pancreatic Ductal Adenocarcinoma (PDAC) Switched Between Soft and Stiff 3D Microgel Culture.
Atkins DJ; Rosas JM; Månsson LK; Shahverdi N; Dey SS; Pitenis AA
ACS Biomater Sci Eng; 2024 Apr; 10(4):2177-2187. PubMed ID: 38466617
[TBL] [Abstract] [Full Text] [Related]
[Next]
